Contact: Patricia A.  Spinella
Investor Relations
(201) 847-5453
Email: patricia_spinella@bd.com

Franklin Lakes, NJ (January 28, 2004) -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today it would participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference. The BD presentation will be made on Wednesday, February 4 at 2:45 p.m. (ET).

The live webcast of BD's presentation can be accessed from the BD website, www.bd.com/investors, and will be available for replay on the BD website until 5:00 p.m. (ET), February 11, 2004.

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2003, BD reported total revenues of $4.528 billion.